Submit Manuscript  

Article Details


Prerequisites for Peptidomic Analysis of Blood Samples: I. Evaluation of Blood Specimen Qualities and Determination of Technical Performance Characteristics

[ Vol. 8 , Issue. 8 ]

Author(s):

Harald Tammen, Imke Schulte, Rudiger Hess, Christoph Menzel, Markus Kellmann and Peter Schulz-Knappe   Pages 725 - 733 ( 9 )

Abstract:


Proteomics studies aiming at a detailed analysis of proteins, and peptidomics, aiming at the analysis of the low molecular weight proteome (peptidome) offer a promising approach to discover novel biomarkers valuable for different crucial steps in detection, prevention and treatment of disease. Much emphasis has been given to the analysis of blood, since this source would by far offer the largest number of meaningful biomarker applications. Blood is a complex liquid tissue that comprises cells and extra-cellular fluid. The choice of suitable specimen collection is crucial to minimize artificial occurring processes during specimen collection and preparation (e.g. cell lysis, proteolysis). After specimen collection, sample preparation for peptidomics is carried out by physical methods (filtration, gel-chromatography, precipitation) which allow for separation based on molecular size, with and without immunodepletion of major abundant proteins. Differential Peptide Display (DPD) is an offline-coupled combination of Reversed-Phase-HPLC and MALDI mass spectrometry in combination with in-house developed data display and analysis tools. Identifications of peptides are carried out by additional mass spectrometric methods (e.g. online LC-ESI-MS/MS). In the work presented here, insights into semi-quantitative mass spectrometric profiling of plasma peptides by DPD are given. This includes proper specimen selection (plasma vs. serum), sample preparation, especially peptide extraction, the determination of sensitivity (i.e. by establishing detection limits of exogenously spiked peptides), the reproducibility for individual as well as for all peptides (Coefficient of Variation calculations) and quantification (correlation between signal intensity and concentration). Finally, the implications for clinical peptidomics are discussed.

Keywords:

Peptidomics, differential peptide display, blood samples, MS analysis, performance

Affiliation:

BioVisioN AG, Feodor-Lynen-Str. 5, D-30625 Hannover, Germany.



Read Full-Text article